The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SALVO: Single-arm phase II study of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma.
 
Robert R. McWilliams
Consulting or Advisory Role - Merrimack (Inst); Zeno Pharmaceuticals
Research Funding - Aduro Biotech (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
 
Shernan Holtan
Consulting or Advisory Role - Bristol-Myers Squibb; CSL Behring; Incyte; Janssen
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Consulting or Advisory Role - Bayer; Takeda
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Bayer; Cardinal Health; Castle Biosciences; Eisai; Exelixis; Janssen; Novartis; Pfizer; Roche/Genentech; TTC Oncology
Travel, Accommodations, Expenses - Newlink Genetics
 
Brendan D. Curti
Consulting or Advisory Role - Alligator Bioscience; Eisai
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune; Prometheus
 
Evidio Domingo Musibay
Honoraria - Regeneron
Consulting or Advisory Role - Immunocore
Speakers' Bureau - Regeneron
Research Funding - Prometheus (Inst)
 
Anthony J. Olszanski
Consulting or Advisory Role - Alkermes; Array BioPharma; EMD Serono; Iovance Biotherapeutics; Merck; Novartis; Pfizer
Research Funding - Adaptimmune (Inst); Alkermes (Inst); Astellas Pharma (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Incyte (Inst); Kartos Therapeutics (Inst); Kura Oncology (Inst); Takeda (Inst); Targovax (Inst)
Travel, Accommodations, Expenses - Takeda
 
Lisa A. Kottschade
Consulting or Advisory Role - Array BioPharma; Eisenhower Health; Immunocore
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
 
Ralph J. Hauke
Stock and Other Ownership Interests - Aethlon
Honoraria - Best Doctors, Inc
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); SOTIO (Inst); US Oncology (Inst)
Other Relationship - ABIM Subspecialty Board